ATE203743T1 - Verbindungen zur modulierung von hormonrezeptoren,diese enthaltende zusammensetzungen und ihre verwendung in therapie - Google Patents
Verbindungen zur modulierung von hormonrezeptoren,diese enthaltende zusammensetzungen und ihre verwendung in therapieInfo
- Publication number
- ATE203743T1 ATE203743T1 AT97401999T AT97401999T ATE203743T1 AT E203743 T1 ATE203743 T1 AT E203743T1 AT 97401999 T AT97401999 T AT 97401999T AT 97401999 T AT97401999 T AT 97401999T AT E203743 T1 ATE203743 T1 AT E203743T1
- Authority
- AT
- Austria
- Prior art keywords
- therapy
- compounds
- compositions containing
- hormone receptors
- containing same
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title 1
- 108091008039 hormone receptors Proteins 0.000 title 1
- 239000000203 mixture Substances 0.000 title 1
- 238000002560 therapeutic procedure Methods 0.000 title 1
- 101100295738 Gallus gallus COR3 gene Proteins 0.000 abstract 1
- 125000003545 alkoxy group Chemical group 0.000 abstract 1
- 125000000217 alkyl group Chemical group 0.000 abstract 1
- 125000000000 cycloalkoxy group Chemical group 0.000 abstract 1
- IPZJQDSFZGZEOY-UHFFFAOYSA-N dimethylmethylene Chemical group C[C]C IPZJQDSFZGZEOY-UHFFFAOYSA-N 0.000 abstract 1
- 125000000623 heterocyclic group Chemical group 0.000 abstract 1
- 125000004029 hydroxymethyl group Chemical group [H]OC([H])([H])* 0.000 abstract 1
- 125000000325 methylidene group Chemical group [H]C([H])=* 0.000 abstract 1
- 150000002790 naphthalenes Chemical class 0.000 abstract 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- GETQZCLCWQTVFV-UHFFFAOYSA-N trimethylamine Chemical compound CN(C)C GETQZCLCWQTVFV-UHFFFAOYSA-N 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
- C07C69/66—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety
- C07C69/73—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety of unsaturated acids
- C07C69/734—Ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/02—Nutrients, e.g. vitamins, minerals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
- A61P31/22—Antivirals for DNA viruses for herpes viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C47/00—Compounds having —CHO groups
- C07C47/20—Unsaturated compounds having —CHO groups bound to acyclic carbon atoms
- C07C47/277—Unsaturated compounds having —CHO groups bound to acyclic carbon atoms containing ether groups, groups, groups, or groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
- C07C59/40—Unsaturated compounds
- C07C59/58—Unsaturated compounds containing ether groups, groups, groups, or groups
- C07C59/72—Unsaturated compounds containing ether groups, groups, groups, or groups containing six-membered aromatic rings and other rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2602/00—Systems containing two condensed rings
- C07C2602/02—Systems containing two condensed rings the rings having only two atoms in common
- C07C2602/04—One of the condensed rings being a six-membered aromatic ring
- C07C2602/10—One of the condensed rings being a six-membered aromatic ring the other ring being six-membered, e.g. tetraline
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Virology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Pain & Pain Management (AREA)
- Molecular Biology (AREA)
- Nutrition Science (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Biotechnology (AREA)
- Rheumatology (AREA)
- Dermatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Steroid Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Cosmetics (AREA)
- Furan Compounds (AREA)
- Pyrane Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR9610686A FR2752837B1 (fr) | 1996-09-02 | 1996-09-02 | Nouveaux composes modulateurs des recepteurs hormonaux, les compositions les comprenant et leur utilisation en therapie |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE203743T1 true ATE203743T1 (de) | 2001-08-15 |
Family
ID=9495359
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT97401999T ATE203743T1 (de) | 1996-09-02 | 1997-08-27 | Verbindungen zur modulierung von hormonrezeptoren,diese enthaltende zusammensetzungen und ihre verwendung in therapie |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US5910508A (de) |
| EP (1) | EP0826657B1 (de) |
| JP (1) | JP2910995B2 (de) |
| AT (1) | ATE203743T1 (de) |
| AU (1) | AU703076B2 (de) |
| CA (1) | CA2213609C (de) |
| DE (1) | DE69705902T2 (de) |
| DK (1) | DK0826657T3 (de) |
| ES (1) | ES2163723T3 (de) |
| FR (1) | FR2752837B1 (de) |
| GR (1) | GR3036997T3 (de) |
| PT (1) | PT826657E (de) |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7655699B1 (en) | 1992-04-22 | 2010-02-02 | Eisai Inc. | Compounds having selective activity for retinoid X receptors, and means for modulation of processes mediated by retinoid X receptors |
| US6566372B1 (en) | 1999-08-27 | 2003-05-20 | Ligand Pharmaceuticals Incorporated | Bicyclic androgen and progesterone receptor modulator compounds and methods |
| KR20020038741A (ko) | 1999-08-27 | 2002-05-23 | 윌리암 엘. 레스페스 | 안드로겐 수용체 조절 화합물 및 방법 |
| JP2003508397A (ja) | 1999-08-27 | 2003-03-04 | リガンド・ファーマシューティカルズ・インコーポレイテッド | アンドロゲンレセプターモジュレーターとしての８−置換−６−トリフルオロメチル−９−ピリド［３，２−ｇ］キノリン化合物 |
| AU7586600A (en) * | 1999-09-14 | 2001-04-17 | Ligand Pharmaceuticals Incorporated | Rxr modulators with improved pharmacologic profile |
| US7314953B2 (en) * | 2001-03-27 | 2008-01-01 | Errant Gene Therapeutics, Llc | Treatment of lung cells with histone deacetylase inhibitors |
| US7312247B2 (en) | 2001-03-27 | 2007-12-25 | Errant Gene Therapeutics, Llc | Histone deacetylase inhibitors |
| US6495719B2 (en) | 2001-03-27 | 2002-12-17 | Circagen Pharmaceutical | Histone deacetylase inhibitors |
| US8026280B2 (en) | 2001-03-27 | 2011-09-27 | Errant Gene Therapeutics, Llc | Histone deacetylase inhibitors |
| US7842727B2 (en) * | 2001-03-27 | 2010-11-30 | Errant Gene Therapeutics, Llc | Histone deacetylase inhibitors |
| EP1511477A4 (de) * | 2002-05-22 | 2008-04-09 | Errant Gene Therapeutics Llc | Histondeacetylase-hemmer auf basis von alpha-ketoepoxid-verbindungen |
| US20060160902A1 (en) * | 2004-11-08 | 2006-07-20 | Wiech Norbert L | Histone deacetylase inhibitors |
| FR2910321B1 (fr) | 2006-12-21 | 2009-07-10 | Galderma Res & Dev S N C Snc | Gel creme comprenant au moins un retinoide et du peroxyde de benzole |
| FR2910320B1 (fr) | 2006-12-21 | 2009-02-13 | Galderma Res & Dev S N C Snc | Emulsion comprenant au moins un retinoide et du peroxyde de benzole |
| FR2931661B1 (fr) | 2008-05-30 | 2010-07-30 | Galderma Res & Dev | Nouvelles compositions depigmentantes sous forme d'une composition anhydre sans vaseline et sans elastomere comprenant un derive phenolique solubilise et un retinoide. |
| US9128079B2 (en) | 2011-08-08 | 2015-09-08 | The Coca-Cola Company | Methods of using lung or bronchial epithelial cells to identify bitter taste modulators |
| KR102170307B1 (ko) * | 2012-11-15 | 2020-10-26 | 주식회사 알엔에스 | 탈모방지 및 모발성장 촉진제 조성물 |
| AU2018367653B2 (en) * | 2017-11-17 | 2020-11-12 | Io Therapeutics, Inc. | Compounds and synthetic methods for the preparation of retinoid X receptor-specific retinoids |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| LU77254A1 (de) * | 1977-05-04 | 1979-01-18 | ||
| AU626881B2 (en) * | 1988-07-14 | 1992-08-13 | F. Hoffmann-La Roche Ag | Benzofused heterocyclics used as pharmaceuticals |
| ATE195716T1 (de) * | 1992-04-22 | 2000-09-15 | Ligand Pharm Inc | Retinoid-x rezeptor selektive verbindungen |
| CA2093577C (en) * | 1992-05-07 | 2006-01-03 | Michael Klaus | Alkyl or alkoxy substituted s-heterocyclic retinoids |
| ES2129115T3 (es) * | 1993-01-11 | 1999-06-01 | Ligand Pharm Inc | Compuestos que tienen actividad selectiva para los receptores de retinoides x, y medios para la modulacion de procesos mediados por receptores de retinoides x. |
-
1996
- 1996-09-02 FR FR9610686A patent/FR2752837B1/fr not_active Expired - Fee Related
-
1997
- 1997-08-27 DE DE69705902T patent/DE69705902T2/de not_active Expired - Fee Related
- 1997-08-27 AT AT97401999T patent/ATE203743T1/de not_active IP Right Cessation
- 1997-08-27 DK DK97401999T patent/DK0826657T3/da active
- 1997-08-27 PT PT97401999T patent/PT826657E/pt unknown
- 1997-08-27 EP EP97401999A patent/EP0826657B1/de not_active Expired - Lifetime
- 1997-08-27 ES ES97401999T patent/ES2163723T3/es not_active Expired - Lifetime
- 1997-08-28 AU AU36059/97A patent/AU703076B2/en not_active Ceased
- 1997-08-29 CA CA002213609A patent/CA2213609C/fr not_active Expired - Fee Related
- 1997-09-01 JP JP9236309A patent/JP2910995B2/ja not_active Expired - Fee Related
- 1997-09-02 US US08/921,591 patent/US5910508A/en not_active Expired - Fee Related
-
2001
- 2001-10-24 GR GR20010401870T patent/GR3036997T3/el not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| AU3605997A (en) | 1998-03-05 |
| FR2752837B1 (fr) | 1999-11-12 |
| DE69705902T2 (de) | 2001-11-15 |
| DK0826657T3 (da) | 2001-10-22 |
| US5910508A (en) | 1999-06-08 |
| CA2213609C (fr) | 2002-06-25 |
| EP0826657A1 (de) | 1998-03-04 |
| JP2910995B2 (ja) | 1999-06-23 |
| PT826657E (pt) | 2001-12-28 |
| CA2213609A1 (fr) | 1998-03-02 |
| JPH10101641A (ja) | 1998-04-21 |
| DE69705902D1 (de) | 2001-09-06 |
| GR3036997T3 (en) | 2002-01-31 |
| EP0826657B1 (de) | 2001-08-01 |
| AU703076B2 (en) | 1999-03-11 |
| ES2163723T3 (es) | 2002-02-01 |
| FR2752837A1 (fr) | 1998-03-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE203743T1 (de) | Verbindungen zur modulierung von hormonrezeptoren,diese enthaltende zusammensetzungen und ihre verwendung in therapie | |
| NZ330118A (en) | Thiophenopyrimidines, pharmaceutical compositions thereof and use in treating endocrine, psychiatric and neurologic conditions | |
| ATE133658T1 (de) | Aromatische verbindungen diese enthaltende pharmazeutische zusammensetzungen und ihre therapeutische verwendung | |
| DE69523169D1 (de) | Verwendung von Mangiferin oder seinen Derivaten zur kosmetischen Anwendung | |
| BG102792A (bg) | Производни на заместени 4-хидроксифенилалканоилови киселини с агонистична активност към рраr-гама | |
| NZ332658A (en) | Halo-substituted bis-indolylmaleimide derivatives and pharmaceutical compositions | |
| JPS6431728A (en) | Improvement on somatostatins | |
| TR199800718T2 (xx) | Herbisid s�lfonamidleri | |
| ATE218329T1 (de) | Anthracyclinon-derivate und ihre verwendung in amyloidose | |
| BG102015A (en) | Azacycloalkane derivatives, their preparation and application in therapy | |
| ES2012648A6 (es) | Procedimiento para la preparacion de nuevos derivados de 1,4-benzoxazina y 1,4-benzotiazina. | |
| PE20001241A1 (es) | Ciertas caprolactamas sustituidas, composiciones farmaceuticas que las contienen, y su uso en el tratamiento de tumores | |
| CO4960660A1 (es) | Derivados de 5-aroil-pirrol-2-ilmetilareno, composiciones farmaceuticas que las contienen y metodos para la preparacion de estos compuestos | |
| SE8303913D0 (sv) | Heterocykliska foreningar | |
| TW347311B (en) | Fungicidal mixtures | |
| HUT76276A (en) | 3-substituted 1-arylindole compounds, pharmaceutical compositions containing them and their use | |
| DE59712053D1 (de) | 4-Amino-2-ureido-pyrimidin-5-carbonsäureamide, Verfahren zu deren Herstellung, diese Verbindungen enthaltende Arzneimittel und deren Verwendung | |
| DE69521895D1 (de) | Indolderivate als prodrugs von "5-ht1-like" rezeptor agonisten | |
| DE3770481D1 (de) | Verwendung von imidazochinazolinen zur behandlung und verhinderung von nephritis. | |
| DE69823650D1 (de) | Azasteroidverbindung zur behandlung oder vorbeugung von prostatakrebs | |
| DE68910090D1 (de) | Verwendung heterozyklischer Amide zur Verhinderung der Tumormetastasierung. | |
| MX9603868A (es) | Composicion farmaceutica de derivados de indeno para la regulacion de la apoptosis. | |
| ATE200673T1 (de) | 1,9-diazabicyclo(4.3.0)nona-3,8-dienderivate | |
| MX9800052A (es) | Compuestos 1,3-dioxan-5-ilamino-heterociclicos sustituidos, procedimientos para su preparacion y su uso como composiciones para controlar plagas. | |
| IT1130486B (it) | Derivati della n dietilaminoetil 2 alcossi benzamide |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification | ||
| REN | Ceased due to non-payment of the annual fee |